| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.916 | 0.003 | 0.916 | Antiadrenergic | 0.209 0.023 CID_10048595 | ||
| 0.915 | 0.003 | 0.915 | Adrenaline antagonist | 0.206 0.022 CID_10048595 | ||
| 0.757 | 0.005 | 0.757 | Cardiotonic | 0.419 0.026 CID_10048595 | ||
| 0.738 | 0.005 | 0.738 | Spasmolytic | 0.665 0.008 CID_10048595 | ||
| 0.729 | 0.005 | 0.729 | Vasodilator, peripheral | 0.641 0.011 CID_10048595 | ||
| 0.695 | 0.007 | 0.695 | 5 Hydroxytryptamine release stimulant | 0.449 0.036 CID_10048595 | ||
| 0.684 | 0.005 | 0.806 | Vasodilator, coronary | 0.806 0.004 CID_10048595 | CID_10048595 | |
| 0.658 | 0.012 | 0.658 | Aldehyde oxidase inhibitor | |||
| 0.627 | 0.002 | 0.627 | Beta adrenoreceptor antagonist | 0.093 0.019 CID_10048595 | ||
| 0.613 | 0.004 | 0.613 | Anesthetic local | |||
| 0.552 | 0.008 | 0.552 | Vasodilator | 0.526 0.01 CID_10048595 | ||
| 0.559 | 0.018 | 0.559 | 5 Hydroxytryptamine release inhibitor | 0.503 0.031 CID_10048595 | ||
| 0.507 | 0.002 | 0.507 | Beta 2 adrenoreceptor antagonist | 0.065 0.02 CID_10048595 | ||
| 0.501 | 0.002 | 0.501 | Beta 1 adrenoreceptor antagonist | 0.056 0.04 CID_10048595 | ||
| 0.534 | 0.048 | 0.534 | Caspase 9 stimulant | 0.514 0.055 CID_10048595 | ||
| 0.501 | 0.032 | 0.677 | Cholesterol antagonist | 0.677 0.01 CID_10048595 | CID_10048595 | |
| 0.466 | 0.01 | 0.466 | P-glycoprotein inhibitor | 0.228 0.049 CID_10048595 | ||
| 0.449 | 0.002 | 0.449 | Beta 3 adrenoreceptor antagonist | 0.065 0.043 CID_10048595 | ||
| 0.454 | 0.007 | 0.454 | Sodium/bile acid cotransporter inhibitor | 0.386 0.022 CID_10048595 | ||
| 0.482 | 0.035 | 0.539 | Histamine release inhibitor | 0.539 0.018 CID_10048595 | CID_10048595 | |
| 0.456 | 0.01 | 0.456 | Cyclic AMP phosphodiesterase inhibitor | 0.421 0.014 CID_10048595 | ||
| 0.443 | 0.003 | 0.443 | Adrenaline agonist | 0.073 0.067 CID_10048595 | ||
| 0.476 | 0.043 | 0.476 | Antiobesity | 0.309 0.11 CID_10048595 | ||
| 0.422 | 0.004 | 0.422 | Nav1.3 sodium channel blocker | |||
| 0.472 | 0.059 | 0.674 | Cyclophilin D inhibitor | 0.674 0.017 CID_10048595 | CID_10048595 | |
| 0.411 | 0.021 | 0.411 | Psychostimulant | 0.294 0.044 CID_10048595 | ||
| 0.422 | 0.044 | 0.756 | Antithrombotic | 0.756 0.005 CID_10048595 | CID_10048595 | |
| 0.375 | 0.008 | 0.375 | Insulin sensitizer | 0.237 0.043 CID_10048595 | ||
| 0.373 | 0.011 | 0.373 | DNA methyltransferase I inhibitor | 0.35 0.014 CID_10048595 | ||
| 0.365 | 0.014 | 0.415 | DNA methylase inhibitor | 0.415 0.01 CID_10048595 | CID_10048595 | |
| 0.35 | 0.012 | 0.454 | Alpha-N-acetylglucosaminidase inhibitor | 0.454 0.007 CID_10048595 | CID_10048595 | |
| 0.311 | 0.011 | 0.311 | Insulin secretagoues | 0.274 0.016 CID_10048595 | ||
| 0.37 | 0.071 | 0.693 | Transcription factor NF kappa B inhibitor | 0.693 0.021 CID_10048595 | CID_10048595 | |
| 0.295 | 0.005 | 0.295 | Calcium antagonist | |||
| 0.323 | 0.033 | 0.323 | Peroxidase inhibitor | |||
| 0.331 | 0.043 | 0.574 | Hypoglycemic | 0.574 0.01 CID_10048595 | CID_10048595 | |
| 0.317 | 0.037 | 0.317 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.321 | 0.05 | 0.321 | DNA damaging | 0.314 0.052 CID_10048595 | ||
| 0.271 | 0.002 | 0.271 | Beta adrenoreceptor agonist | 0.046 0.027 CID_10048595 | ||
| 0.285 | 0.017 | 0.285 | Interleukin 6 antagonist | 0.185 0.051 CID_10048595 | ||
| 0.3 | 0.033 | 0.3 | Gastrin inhibitor | 0.233 0.101 CID_10048595 | ||
| 0.311 | 0.048 | 0.311 | Transcription factor STAT3 inhibitor | |||
| 0.303 | 0.046 | 0.449 | Interleukin agonist | 0.449 0.013 CID_10048595 | CID_10048595 | |
| 0.244 | 0.004 | 0.244 | Adenylate cyclase stimulant | 0.172 0.033 CID_10048595 | ||
| 0.324 | 0.101 | 0.488 | Immunosuppressant | 0.488 0.036 CID_10048595 | CID_10048595 | |
| 0.245 | 0.023 | 0.245 | Nav1.2 sodium channel blocker | |||
| 0.233 | 0.012 | 0.233 | Nav1.6 sodium channel blocker | |||
| 0.234 | 0.014 | 0.234 | Nav1.1 sodium channel blocker | |||
| 0.298 | 0.079 | 0.565 | Immunostimulant | 0.565 0.021 CID_10048595 | CID_10048595 | |
| 0.283 | 0.066 | 0.283 | Transcription factor STAT inhibitor | |||
| 0.238 | 0.022 | 0.238 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.224 | 0.011 | 0.224 | Catalase inhibitor | |||
| 0.224 | 0.022 | 0.324 | ATPase inhibitor | 0.324 0.005 CID_10048595 | CID_10048595 | |
| 0.234 | 0.034 | 0.234 | Diuretic | 0.226 0.036 CID_10048595 | ||
| 0.211 | 0.019 | 0.211 | Toll-Like receptor 2 antagonist | 0.112 0.087 CID_10048595 | ||
| 0.196 | 0.005 | 0.216 | Glutamate release inhibitor | 0.216 0.004 CID_10048595 | CID_10048595 | |
| 0.254 | 0.064 | 0.254 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.184 | 0.002 | 0.184 | Beta 1 adrenoreceptor agonist | |||
| 0.207 | 0.027 | 0.207 | Calcium channel blocker | |||
| 0.178 | 0.002 | 0.178 | Beta 3 adrenoreceptor agonist | |||
| 0.242 | 0.072 | 0.412 | DNA synthesis inhibitor | 0.412 0.02 CID_10048595 | CID_10048595 | |
| 0.224 | 0.055 | 0.224 | Nitric-oxide synthase stimulant | 0.187 0.113 CID_10048595 | ||
| 0.263 | 0.102 | 0.293 | Caspase 3 stimulant | 0.293 0.082 CID_10048595 | CID_10048595 | |
| 0.175 | 0.016 | 0.175 | Sphingomyelinase inhibitor | 0.152 0.024 CID_10048595 | ||
| 0.238 | 0.082 | 0.238 | Superoxide dismutase inhibitor | |||
| 0.223 | 0.073 | 0.358 | Peptidyltransferase inhibitor | 0.358 0.011 CID_10048595 | CID_10048595 | |
| 0.154 | 0.004 | 0.154 | 5 Hydroxytryptamine 1B agonist | |||
| 0.161 | 0.013 | 0.161 | MAP kinase kinase 1 inhibitor | |||
| 0.301 | 0.157 | 0.301 | Calcium channel L-type activator | |||
| 0.144 | 0.003 | 0.144 | Beta 2 adrenoreceptor agonist | |||
| 0.145 | 0.004 | 0.145 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.137 | 0.003 | 0.137 | Calcium-sensing receptor antagonist | |||
| 0.169 | 0.034 | 0.169 | Adenylate cyclase inhibitor | 0.111 0.074 CID_10048595 | ||
| 0.271 | 0.137 | 0.271 | GABA C receptor rho-3 antagonist | |||
| 0.216 | 0.084 | 0.283 | Hypolipemic | 0.283 0.054 CID_10048595 | CID_10048595 | |
| 0.16 | 0.028 | 0.16 | Bronchodilator | |||
| 0.241 | 0.109 | 0.241 | Hypoxia-inducible factor 1 alpha inhibitor | 0.206 0.145 CID_10048595 | ||
| 0.157 | 0.028 | 0.157 | Mucolytic | 0.14 0.039 CID_10048595 | ||
| 0.151 | 0.023 | 0.151 | Creatine kinase inhibitor | |||
| 0.183 | 0.057 | 0.183 | Phospholipase C inhibitor | 0.153 0.099 CID_10048595 | ||
| 0.217 | 0.092 | 0.217 | Neuropeptide Y2 antagonist | |||
| 0.129 | 0.004 | 0.129 | Sphingosine 1-phosphate receptor agonist | |||
| 0.136 | 0.014 | 0.136 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.135 | 0.016 | 0.135 | Ornithine decarboxylase inhibitor | |||
| 0.142 | 0.025 | 0.179 | Topoisomerase II alpha inhibitor | 0.179 0.018 CID_10048595 | CID_10048595 | |
| 0.139 | 0.024 | 0.139 | Factor V inhibitor | 0.107 0.056 CID_10048595 | ||
| 0.198 | 0.085 | 0.198 | Interleukin antagonist | |||
| 0.192 | 0.079 | 0.192 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.155 0.138 CID_10048595 | ||
| 0.207 | 0.095 | 0.397 | Antiamyloidogenic | 0.397 0.029 CID_10048595 | CID_10048595 | |
| 0.124 | 0.015 | 0.124 | Calcium channel L-type blocker | |||
| 0.154 | 0.045 | 0.27 | Alkylator | 0.27 0.014 CID_10048595 | CID_10048595 | |
| 0.126 | 0.021 | 0.126 | Somatostatin 1 agonist | 0.077 0.055 CID_10048595 | ||
| 0.125 | 0.02 | 0.125 | Keratolytic | |||
| 0.307 | 0.203 | 0.307 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.141 | 0.039 | 0.275 | Expectorant | 0.275 0.01 CID_10048595 | CID_10048595 | |
| 0.136 | 0.037 | 0.136 | Nav1.5 sodium channel blocker | |||
| 0.141 | 0.042 | 0.141 | Aminopeptidase B inhibitor | |||
| 0.128 | 0.029 | 0.128 | Alcohol dehydrogenase inhibitor | 0.089 0.065 CID_10048595 | ||
| 0.138 | 0.041 | 0.138 | Alpha adrenoreceptor antagonist | |||
| 0.146 | 0.05 | 0.146 | Aldehyde dehydrogenase inhibitor | 0.108 0.085 CID_10048595 | ||
| 0.1 | 0.005 | 0.1 | Calcium channel P-type blocker | |||
| 0.116 | 0.021 | 0.116 | Aminopeptidase I inhibitor | |||
| 0.171 | 0.078 | 0.171 | Succinate dehydrogenase inhibitor | |||
| 0.113 | 0.021 | 0.113 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.096 | 0.005 | 0.096 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.106 | 0.015 | 0.106 | Secretase beta inhibitor | |||
| 0.184 | 0.093 | 0.184 | MAP kinase kinase 2 inhibitor | |||
| 0.106 | 0.017 | 0.106 | Cathepsin D inhibitor | |||
| 0.152 | 0.063 | 0.152 | Neuropeptide Y1 antagonist | |||
| 0.155 | 0.069 | 0.157 | Phospholipase A2 inhibitor | 0.157 0.068 CID_10048595 | CID_10048595 | |
| 0.128 | 0.042 | 0.128 | Protease inhibitor | |||
| 0.124 | 0.041 | 0.251 | UDP-glucose 4-epimerase inhibitor | 0.251 0.013 CID_10048595 | CID_10048595 | |
| 0.123 | 0.04 | 0.185 | Toll-Like receptor 4 antagonist | 0.185 0.009 CID_10048595 | CID_10048595 | |
| 0.158 | 0.079 | 0.158 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.147 | 0.068 | 0.147 | MAP kinase kinase 4 inhibitor | |||
| 0.084 | 0.014 | 0.084 | Sphingosine kinase inhibitor | |||
| 0.139 | 0.069 | 0.372 | Amylase inhibitor | 0.372 0.011 CID_10048595 | CID_10048595 | |
| 0.156 | 0.087 | 0.156 | Neurotensin receptor agonist | |||
| 0.107 | 0.037 | 0.207 | NADH dehydrogenase inhibitor | 0.207 0.01 CID_10048595 | CID_10048595 | |
| 0.102 | 0.033 | 0.102 | Histamine H2 receptor antagonist | |||
| 0.118 | 0.049 | 0.194 | Mediator release inhibitor | 0.194 0.015 CID_10048595 | CID_10048595 | |
| 0.127 | 0.06 | 0.127 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.149 | 0.083 | 0.178 | Melanin inhibitor | 0.178 0.053 CID_10048595 | CID_10048595 | |
| 0.073 | 0.007 | 0.073 | Plasmepsin II inhibitor | |||
| 0.08 | 0.015 | 0.08 | Sphingosine kinase 2 inhibitor | |||
| 0.088 | 0.024 | 0.088 | Phospholipase D inhibitor | |||
| 0.111 | 0.048 | 0.111 | GABA C receptor rho-1 antagonist | |||
| 0.121 | 0.058 | 0.121 | Caspase 3 inhibitor | |||
| 0.074 | 0.015 | 0.074 | Epithelial sodium channel blocker | |||
| 0.218 | 0.16 | 0.441 | Interleukin 2 agonist | 0.441 0.017 CID_10048595 | CID_10048595 | |
| 0.126 | 0.068 | 0.126 | MAP kinase kinase inhibitor | |||
| 0.111 | 0.052 | 0.111 | Adenylate kinase inhibitor | |||
| 0.079 | 0.021 | 0.079 | Heat shock protein 90 beta antagonist | |||
| 0.071 | 0.014 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.087 | 0.03 | 0.087 | Phosphodiesterase III inhibitor | |||
| 0.102 | 0.046 | 0.15 | Triose-phosphate isomerase inhibitor | 0.15 0.02 CID_10048595 | CID_10048595 | |
| 0.116 | 0.061 | 0.116 | Calcium channel (voltage-sensitive) blocker | |||
| 0.098 | 0.043 | 0.106 | ATPase (Vacuolar H+) inhibitor | 0.106 0.033 CID_10048595 | CID_10048595 | |
| 0.058 | 0.005 | 0.058 | Plasmepsin I inhibitor | |||
| 0.137 | 0.084 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.137 0.087 CID_10048595 | ||
| 0.071 | 0.018 | 0.071 | Myc inhibitor | |||
| 0.103 | 0.051 | 0.113 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.113 0.043 CID_10048595 | CID_10048595 | |
| 0.203 | 0.152 | 0.203 | Insulysin inhibitor | |||
| 0.14 | 0.09 | 0.275 | Thrombolytic | 0.275 0.028 CID_10048595 | CID_10048595 | |
| 0.125 | 0.075 | 0.125 | Vanilloid 1 agonist | 0.116 0.099 CID_10048595 | ||
| 0.143 | 0.093 | 0.143 | Growth hormone agonist | |||
| 0.087 | 0.037 | 0.087 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.098 | 0.05 | 0.098 | Alpha 2 adrenoreceptor antagonist | |||
| 0.055 | 0.012 | 0.055 | Sphingosine kinase 1 inhibitor | |||
| 0.222 | 0.182 | 0.222 | Calcium channel activator | |||
| 0.209 | 0.168 | 0.477 | Apoptosis antagonist | 0.477 0.023 CID_10048595 | CID_10048595 | |
| 0.078 | 0.038 | 0.343 | Selectin antagonist | 0.343 0.004 CID_10048595 | CID_10048595 | |
| 0.103 | 0.062 | 0.103 | Gastric antisecretory | |||
| 0.122 | 0.082 | 0.122 | Sodium channel blocker | |||
| 0.118 | 0.078 | 0.118 | Cathepsin H inhibitor | |||
| 0.132 | 0.092 | 0.434 | Hemostatic | 0.434 0.006 CID_10048595 | CID_10048595 | |
| 0.087 | 0.047 | 0.087 | Estrogen-related receptor beta agonist | |||
| 0.082 | 0.042 | 0.082 | Glutamate decarboxylase inhibitor | |||
| 0.132 | 0.093 | 0.132 | Acetylcholine M1 receptor antagonist | |||
| 0.073 | 0.034 | 0.073 | 5 Hydroxytryptamine 2A agonist | |||
| 0.112 | 0.074 | 0.223 | Topoisomerase II inhibitor | 0.223 0.029 CID_10048595 | CID_10048595 | |
| 0.096 | 0.06 | 0.112 | Phosphodiesterase 6D inhibitor | 0.112 0.034 CID_10048595 | CID_10048595 | |
| 0.106 | 0.07 | 0.106 | GABA C receptor antagonist | |||
| 0.079 | 0.043 | 0.079 | Vanilloid 4 agonist | |||
| 0.061 | 0.025 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.013 CID_10048595 | CID_10048595 | |
| 0.054 | 0.019 | 0.054 | Geranyltranstransferase inhibitor | |||
| 0.11 | 0.075 | 0.11 | Proteasome inhibitor | |||
| 0.097 | 0.062 | 0.097 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | |||
| 0.066 | 0.033 | 0.066 | Cathepsin E inhibitor | |||
| 0.175 | 0.143 | 0.175 | RNA-directed DNA polymerase inhibitor | |||
| 0.068 | 0.036 | 0.068 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.078 | 0.048 | 0.078 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.077 | 0.048 | 0.077 | Glutamate dehydrogenase inhibitor | |||
| 0.099 | 0.071 | 0.299 | AMP-activated protein kinase stimulant | 0.299 0.005 CID_10048595 | CID_10048595 | |
| 0.036 | 0.007 | 0.036 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.04 | 0.012 | 0.04 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.097 | 0.07 | 0.097 | Folate antagonist | 0.092 0.083 CID_10048595 | ||
| 0.051 | 0.024 | 0.074 | Mannosidase inhibitor | 0.074 0.01 CID_10048595 | CID_10048595 | |
| 0.057 | 0.032 | 0.057 | Immunoglobulin Fc receptor antagonist | |||
| 0.106 | 0.081 | 0.136 | Microtubule formation inhibitor | 0.136 0.046 CID_10048595 | CID_10048595 | |
| 0.084 | 0.06 | 0.084 | NMDA receptor antagonist | |||
| 0.049 | 0.026 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 CID_10048595 | CID_10048595 | |
| 0.058 | 0.037 | 0.058 | Alcohol oxidase inhibitor | |||
| 0.11 | 0.089 | 0.211 | Cyclooxygenase 3 inhibitor | 0.211 0.015 CID_10048595 | CID_10048595 | |
| 0.046 | 0.025 | 0.046 | HIV-1 protease inhibitor | |||
| 0.167 | 0.146 | 0.494 | Antioxidant | 0.494 0.021 CID_10048595 | CID_10048595 | |
| 0.055 | 0.035 | 0.055 | Ornithine carbamoyltransferase inhibitor | |||
| 0.039 | 0.019 | 0.051 | Squalene synthetase inhibitor | 0.051 0.014 CID_10048595 | CID_10048595 | |
| 0.062 | 0.043 | 0.062 | Prostaglandin F2 alpha antagonist | |||
| 0.024 | 0.005 | 0.044 | Antibiotic Anthracycline-like | 0.044 0.002 CID_10048595 | CID_10048595 | |
| 0.064 | 0.045 | 0.12 | Neuraminidase (influenza) inhibitor | 0.12 0.012 CID_10048595 | CID_10048595 | |
| 0.067 | 0.048 | 0.067 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.053 | 0.034 | 0.053 | Aconitate hydratase inhibitor | |||
| 0.074 | 0.056 | 0.074 | Alpha 1 adrenoreceptor antagonist | |||
| 0.092 | 0.074 | 0.092 | Anabolic | |||
| 0.125 | 0.107 | 0.125 | Thiol protease inhibitor | |||
| 0.069 | 0.052 | 0.069 | Histidine decarboxylase inhibitor | |||
| 0.129 | 0.112 | 0.198 | Interferon gamma antagonist | 0.198 0.041 CID_10048595 | CID_10048595 | |
| 0.051 | 0.034 | 0.051 | CD45 antagonist | |||
| 0.062 | 0.045 | 0.071 | Nitric oxide donor | 0.071 0.032 CID_10048595 | CID_10048595 | |
| 0.058 | 0.042 | 0.058 | Carbonic anhydrase stimulant | |||
| 0.045 | 0.03 | 0.045 | Dihydroorotase inhibitor | |||
| 0.055 | 0.041 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.057 | 0.043 | 0.057 | Alpha 1d adrenoreceptor antagonist | |||
| 0.029 | 0.015 | 0.029 | Myristoyl transferase inhibitor | |||
| 0.057 | 0.043 | 0.057 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.1 | 0.087 | 0.1 | Cholesterol synthesis inhibitor | |||
| 0.053 | 0.04 | 0.053 | Human rhinovirus A protease inhibitor | |||
| 0.052 | 0.04 | 0.052 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.103 | 0.093 | 0.103 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.066 | 0.056 | 0.066 | Alpha 1b adrenoreceptor antagonist | |||
| 0.113 | 0.103 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.112 | 0.103 | 0.218 | Lipid peroxidase inhibitor | 0.218 0.035 CID_10048595 | CID_10048595 | |
| 0.057 | 0.048 | 0.057 | Adrenaline uptake inhibitor | |||
| 0.051 | 0.042 | 0.051 | Leukotriene B4 antagonist | 0.05 0.044 CID_10048595 | ||
| 0.094 | 0.086 | 0.094 | Chelator | 0.093 0.087 CID_10048595 | ||
| 0.039 | 0.031 | 0.039 | VCAM-1 antagonist | |||
| 0.056 | 0.048 | 0.096 | Neuraminidase inhibitor | 0.096 0.017 CID_10048595 | CID_10048595 | |
| 0.038 | 0.031 | 0.038 | VCAM antagonist | |||
| 0.087 | 0.08 | 0.087 | Electrolyte absorption antagonist | |||
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.101 | 0.094 | 0.101 | Calcium channel N-type blocker | |||
| 0.046 | 0.04 | 0.046 | Bombesin 2 receptor antagonist | |||
| 0.086 | 0.081 | 0.086 | Carbonic anhydrase III inhibitor | |||
| 0.108 | 0.102 | 0.108 | Antibacterial (Helicobacter pylori) | |||
| 0.027 | 0.021 | 0.027 | Hedgehog signaling activator | |||
| 0.069 | 0.066 | 0.069 | Potassium channel (Tandem pore domain) blocker | |||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.016 | 0.014 | 0.016 | Vitamin D receptor agonist | |||
| 0.07 | 0.07 | 0.08 | Interferon agonist | 0.08 0.052 CID_10048595 | CID_10048595 | |
| 0.043 | 0.043 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.027 CID_10048595 | CID_10048595 | |
| 0.058 | 0.059 | 0.111 | Phosphofructokinase-1 inhibitor | 0.111 0.028 CID_10048595 | CID_10048595 | |
| 0.147 | 0.148 | 0.275 | Platelet antagonist | 0.275 0.062 CID_10048595 | CID_10048595 | |
| 0.013 | 0.019 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_10048595 | CID_10048595 | |
| 0.084 | 0.095 | 0.127 | DNA intercalator | 0.127 0.054 CID_10048595 | CID_10048595 | |
| 0.043 | 0.054 | 0.055 | Cytokine production stimulant | 0.055 0.019 CID_10048595 | CID_10048595 | |
| 0.103 | 0.119 | 0.177 | DNA repair enzyme inhibitor | 0.177 0.014 CID_10048595 | CID_10048595 | |
| 0.023 | 0.039 | 0.051 | Arginase inhibitor | 0.051 0.015 CID_10048595 | CID_10048595 | |
| 0.052 | 0.077 | 0.059 | Interferon inducer | 0.059 0.057 CID_10048595 | CID_10048595 | |
| 0.099 | 0.124 | 0.121 | Protein kinase stimulant | 0.121 0.091 CID_10048595 | CID_10048595 | |
| 0.027 | 0.054 | 0.066 | Antibiotic Aminoglycoside-like | 0.066 0.007 CID_10048595 | CID_10048595 | |
| 0.087 | 0.12 | 0.117 | Photosensitizer | 0.117 0.06 CID_10048595 | CID_10048595 | |
| 0.05 | 0.084 | 0.089 | Na+ K+ transporting ATPase inhibitor | 0.089 0.042 CID_10048595 | CID_10048595 | |
| 0.111 | 0.15 | 0.562 | Angiogenesis stimulant | 0.562 0.009 CID_10048595 | CID_10048595 | |
| 0.215 | 0.255 | 0.526 | Apoptosis agonist | 0.526 0.067 CID_10048595 | CID_10048595 | |
| 0.014 | 0.059 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.053 0.006 CID_10048595 | CID_10048595 | |
| 0.016 | 0.064 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 CID_10048595 | CID_10048595 | |
| 0.096 | 0.147 | 0.208 | Cell wall synthesis inhibitor | 0.208 0.027 CID_10048595 | CID_10048595 | |
| 0.064 | 0.123 | 0.129 | Transcription factor NF kappa B stimulant | 0.129 0.021 CID_10048595 | CID_10048595 | |
| 0.087 | 0.146 | 0.132 | Interleukin 4 antagonist | 0.132 0.069 CID_10048595 | CID_10048595 | |
| 0.105 | 0.165 | 0.342 | Nitric oxide antagonist | 0.342 0.033 CID_10048595 | CID_10048595 | |
| 0.027 | 0.093 | 0.042 | Microtubule stabilization | 0.042 0.039 CID_10048595 | CID_10048595 | |
| 0.068 | 0.137 | 0.149 | DNA polymerase I inhibitor | 0.149 0.05 CID_10048595 | CID_10048595 | |
| 0.035 | 0.108 | 0.176 | Antineoplastic antibiotic | 0.176 0.025 CID_10048595 | CID_10048595 | |
| 0.02 | 0.097 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 CID_10048595 | CID_10048595 | |
| 0.012 | 0.093 | 0.039 | Protein 30S ribosomal subunit inhibitor | 0.039 0.01 CID_10048595 | CID_10048595 | |
| 0.032 | 0.121 | 0.094 | Heparanase inhibitor | 0.094 0.004 CID_10048595 | CID_10048595 | |
| 0.046 | 0.138 | 0.206 | Monophenol monooxygenase inhibitor | 0.206 0.032 CID_10048595 | CID_10048595 | |
| 0.094 | 0.188 | 0.332 | Platelet adhesion inhibitor | 0.332 0.024 CID_10048595 | CID_10048595 | |
| 0.039 | 0.134 | 0.086 | Adenine nucleotide translocase inhibitor | 0.086 0.007 CID_10048595 | CID_10048595 | |
| 0.084 | 0.184 | 0.155 | Amyloid beta aggregation inhibitor | 0.155 0.104 CID_10048595 | CID_10048595 | |
| 0.06 | 0.164 | 0.089 | Xanthine oxidase inhibitor | 0.089 0.073 CID_10048595 | CID_10048595 | |
| 0.05 | 0.154 | 0.096 | Protein-tyrosine phosphatase 1B inhibitor | 0.096 0.082 CID_10048595 | CID_10048595 | |
| 0.096 | 0.202 | 0.383 | Hepatoprotectant | 0.383 0.015 CID_10048595 | CID_10048595 | |
| 0.106 | 0.215 | 0.439 | Free radical scavenger | 0.439 0.023 CID_10048595 | CID_10048595 | |
| 0.109 | 0.219 | 0.371 | Tumour necrosis factor alpha release inhibitor | 0.371 0.033 CID_10048595 | CID_10048595 | |
| 0.048 | 0.173 | 0.105 | Cell adhesion molecule inhibitor | 0.105 0.031 CID_10048595 | CID_10048595 | |
| 0.016 | 0.145 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_10048595 | CID_10048595 | |
| 0.04 | 0.175 | 0.172 | Topoisomerase I inhibitor | 0.172 0.034 CID_10048595 | CID_10048595 | |
| 0.068 | 0.204 | 0.181 | Cell adhesion inhibitor | 0.181 0.031 CID_10048595 | CID_10048595 | |
| 0.154 | 0.292 | 0.566 | Antibacterial | 0.566 0.025 CID_10048595 | CID_10048595 | |
| 0.079 | 0.218 | 0.131 | Hexokinase inhibitor | 0.131 0.103 CID_10048595 | CID_10048595 | |
| 0.026 | 0.176 | 0.067 | Factor IXa inhibitor | 0.067 0.022 CID_10048595 | CID_10048595 | |
| 0.127 | 0.287 | 0.389 | Immunomodulator | 0.389 0.047 CID_10048595 | CID_10048595 | |
| 0.037 | 0.218 | 0.057 | Lipocortins synthesis agonist | 0.057 0.042 CID_10048595 | CID_10048595 | |
| 0.017 | 0.203 | 0.091 | Protein 50S ribosomal subunit inhibitor | 0.091 0.016 CID_10048595 | CID_10048595 | |
| 0.06 | 0.252 | 0.201 | Anticoagulant | 0.201 0.052 CID_10048595 | CID_10048595 | |
| 0.023 | 0.23 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 CID_10048595 | CID_10048595 | |
| 0.066 | 0.393 | 0.295 | Alpha-glucosidase inhibitor | 0.295 0.162 CID_10048595 | CID_10048595 | |
| 0.03 | 0.362 | 0.101 | Beta glucuronidase inhibitor | 0.101 0.068 CID_10048595 | CID_10048595 | |
| 0.081 | 0.531 | 0.131 | CC chemokine 6 receptor antagonist | 0.131 0.069 CID_10048595 | CID_10048595 | |
| 0.037 | 0.615 | 0.147 | NOS3 expression enhancer | 0.147 0.076 CID_10048595 | CID_10048595 | |
| 0.043 | 0.711 | 0.533 | Antiinflammatory | 0.533 0.074 CID_10048595 | CID_10048595 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |